Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × neratinib × Clear all

NCT03919292 2025-04-16

Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

Phase 1/2 Recruiting

Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Disease Progression